CYCLOTRONS2022 - List of Authors (Donzel, X.)

Paper	Title	Page
THBI01	Status on NHa C400 Cyclotron for Hadrontherapy	264
	J. Mandrillon, M. Abs, P. Cailliau, S. Deprez, X. Donzel, G. Goosse, Y. Jongen, W.J.G.M. Kleeven, L.C.L. Koffel, V. Nuttens, Y. Otu, Y. Paradis IBA, Louvain-la-Neuve, Belgium O. Cosson, L. Maunoury, Ph. Velten NHa, Caen, France
	C400 is an isochronous cyclotron for cancer therapy delivering high dose rates of alphas to carbons at 400 MeV/amu extracted by electrostatic deflector and protons at 260 MeV extracted by stripping of molecular hydrogen. IBA started to pre-design the system more than 13 years ago in collaboration with JINR. The responsibility for the development of C400 has meanwhile been taken over by the French company Normandy Hadontherapy (NHa). However, the study and design work continued with a very strong involvement of IBA for the past 3 years, from concept on paper to reality. We will describe the most innovative concepts and technical solutions on the accelerator from source to extraction and show the construction progress.
	Slides THBI01 [6.375 MB]
DOI •	reference for this paper ※ doi:10.18429/JACoW-CYCLOTRONS2022-THBI01
About •	Received ※ 08 December 2022 — Revised ※ 12 January 2023 — Accepted ※ 31 January 2023 — Issue date ※ 18 February 2023
Cite •	reference for this paper using ※ BibTeX, ※ LaTeX, ※ Text/Word, ※ RIS, ※ EndNote (xml)

Paper

Title

Page

Status on NHa C400 Cyclotron for Hadrontherapy

264

J. Mandrillon, M. Abs, P. Cailliau, S. Deprez, X. Donzel, G. Goosse, Y. Jongen, W.J.G.M. Kleeven, L.C.L. Koffel, V. Nuttens, Y. Otu, Y. Paradis
IBA, Louvain-la-Neuve, Belgium
O. Cosson, L. Maunoury, Ph. Velten
NHa, Caen, France

C400 is an isochronous cyclotron for cancer therapy delivering high dose rates of alphas to carbons at 400 MeV/amu extracted by electrostatic deflector and protons at 260 MeV extracted by stripping of molecular hydrogen. IBA started to pre-design the system more than 13 years ago in collaboration with JINR. The responsibility for the development of C400 has meanwhile been taken over by the French company Normandy Hadontherapy (NHa). However, the study and design work continued with a very strong involvement of IBA for the past 3 years, from concept on paper to reality. We will describe the most innovative concepts and technical solutions on the accelerator from source to extraction and show the construction progress.

Slides THBI01 [6.375 MB]

DOI •

reference for this paper ※ doi:10.18429/JACoW-CYCLOTRONS2022-THBI01

About •

Received ※ 08 December 2022 — Revised ※ 12 January 2023 — Accepted ※ 31 January 2023 — Issue date ※ 18 February 2023

Cite •

reference for this paper using ※ BibTeX, ※ LaTeX, ※ Text/Word, ※ RIS, ※ EndNote (xml)